Literature DB >> 30537116

HMGB1+ microparticles present in urine are hallmarks of nephritis in patients with systemic lupus erythematosus.

Catalina Burbano1,2, Jóse A Gómez-Puerta1,3, Carlos Muñoz-Vahos4, Adriana Vanegas-García4, Mauricio Rojas1,2, Gloria Vásquez1,4, Diana Castaño1,5.   

Abstract

Non-classical monocytes infiltrate the kidney parenchyma and participate in tissue damage in patients with lupus nephritis (LN). Circulating microparticles (MPs) seem to play critical roles in the activation of monocytes in systemic lupus erythematosus (SLE) patients. This study aims to characterize the phenotypes of MPs and monocyte subsets in LN patients and to determine their potential to discriminate between SLE patients with and without LN. Blood and urine samples from SLE patients were collected. In monocyte subsets from whole blood samples several phenotypic markers were evaluated. MPs were isolated from platelet-poor plasma and urine by centrifugation. This phenotypic marker characterization was performed using multiparametric flow cytometry. We observed that patients with active LN have lower counts of non-classical monocytes than do those without renal involvement. All monocyte subsets exhibited lower expression of CX3CR1 and ICAM-1 in LN than in patients without LN. High frequencies of MP-HMGB1+ and MP-HLA-DR+ were detected in circulation and urine of LN patients. Although MP-HMGB1+ , MP-HLA-DR+ , and MP-CX3CR1+ from urine were able to discriminate between patients with and without LN, only urinary MP-HMGB1+ were different between patients with active and inactive LN. Therefore, these vesicles may be useful as biomarkers of LN.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  CX3CR1; HMGB1; Microparticles; Monocyte subsets; Systemic lupus erythematosus

Year:  2019        PMID: 30537116     DOI: 10.1002/eji.201847747

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  13 in total

Review 1.  Complement System and Alarmin HMGB1 Crosstalk: For Better or Worse.

Authors:  Christine Gaboriaud; Marie Lorvellec; Véronique Rossi; Chantal Dumestre-Pérard; Nicole M Thielens
Journal:  Front Immunol       Date:  2022-04-28       Impact factor: 8.786

Review 2.  Lupus nephritis: challenges and progress.

Authors:  Anne Davidson; Cynthia Aranow; Meggan Mackay
Journal:  Curr Opin Rheumatol       Date:  2019-11       Impact factor: 5.006

3.  Podocyte-Released Migrasomes in Urine Serve as an Indicator for Early Podocyte Injury.

Authors:  Ying Liu; Shan Li; Weiwei Rong; Caihong Zeng; Xiaodong Zhu; Qilin Chen; Limin Li; Zhi-Hong Liu; Ke Zen
Journal:  Kidney Dis (Basel)       Date:  2020-10-23

4.  Co-Delivery Of Dihydroartemisinin And HMGB1 siRNA By TAT-Modified Cationic Liposomes Through The TLR4 Signaling Pathway For Treatment Of Lupus Nephritis.

Authors:  Lu Diao; Jin Tao; Yiqi Wang; Ying Hu; Wenfei He
Journal:  Int J Nanomedicine       Date:  2019-11-04

Review 5.  Extracellular Vesicles in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Functions and Applications.

Authors:  Bo Zhang; Ming Zhao; Qianjin Lu
Journal:  Front Immunol       Date:  2021-01-14       Impact factor: 7.561

6.  Induction of NF-κB inflammatory pathway in monocytes by microparticles from patients with systemic lupus erythematosus.

Authors:  Karen Álvarez; Juan Villar-Vesga; Blanca Ortiz-Reyes; Adriana Vanegas-García; Diana Castaño; Mauricio Rojas; Gloria Vásquez
Journal:  Heliyon       Date:  2020-12-23

Review 7.  Extracellular Vesicles Tune the Immune System in Renal Disease: A Focus on Systemic Lupus Erythematosus, Antiphospholipid Syndrome, Thrombotic Microangiopathy and ANCA-Vasculitis.

Authors:  Martina Mazzariol; Giovanni Camussi; Maria Felice Brizzi
Journal:  Int J Mol Sci       Date:  2021-04-18       Impact factor: 5.923

Review 8.  The Role of HMGB1 in Rheumatic Diseases.

Authors:  Yuanji Dong; Bingxia Ming; Lingli Dong
Journal:  Front Immunol       Date:  2022-02-17       Impact factor: 7.561

Review 9.  Extracellular vesicles and lupus nephritis - New insights into pathophysiology and clinical implications.

Authors:  Yin Zhao; Wei Wei; Ming-Lin Liu
Journal:  J Autoimmun       Date:  2020-09-04       Impact factor: 14.511

Review 10.  HMGB1 in Systemic Lupus Erythematosus.

Authors:  Tianye Liu; Myoungsun Son; Betty Diamond
Journal:  Front Immunol       Date:  2020-05-27       Impact factor: 8.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.